Antigua and Barbuda vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy

Antigua and Barbuda
0 patients
in 2021
Yemen
0 patients
in 2020
Antigua and Barbuda rank
141st
Yemen rank
141st

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Antigua and Barbuda
  • Yemen
0102030200320122021

How they compare

Antigua and Barbuda currently reports 0 patients against 0 patients in Yemen, a difference of 0 patients.

The two have swapped places 5 times across 12 shared years of data; in 2005 it was Antigua and Barbuda ahead.

Antigua and Barbuda ranks 141st and Yemen ranks 141st of 183 countries.

Across the 3 decades both report, Antigua and Barbuda averaged higher in 1 and Yemen in 1.

Head to head by decade

Decade Antigua and Barbuda Yemen Difference Ahead
2000s 1.5 patients 0 patients 1.5 patients Antigua and Barbuda
2010s 1.71 patients 6 patients 4.29 patients Yemen
2020s 0 patients 0 patients 0 patients

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Antigua and Barbuda or Yemen?
Antigua and Barbuda, at 0 patients against 0 patients in Yemen as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Antigua and Barbuda and Yemen?
0 patients, with Antigua and Barbuda ahead.
How many years of comparable data are there for Antigua and Barbuda and Yemen?
12 years are reported by both, from 2005 to 2020.
How do Antigua and Barbuda and Yemen rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Antigua and Barbuda ranks 141st and Yemen ranks 141st of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Antigua and Barbuda vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 15 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/antigua-and-barbuda/yemen-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/antigua-and-barbuda/yemen-rep/">Antigua and Barbuda vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.